Información de la revista
Vol. 17. Núm. 3.
Páginas 132-136 (marzo 2021)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Visitas
5254
Vol. 17. Núm. 3.
Páginas 132-136 (marzo 2021)
Original Article
Acceso a texto completo
Evaluation of brain changes in systemic sclerosis (SSc) patients using two different techniques of MRI: Is it really worthy?
Evaluación de los cambios cerebrales en pacientes con esclerosis sistémica que utilizan 2 técnicas diferentes de resonancia magnética: ¿es realmente valiosa?
Visitas
5254
Rania M. Gamala, Abeer M. Ghandoura, Mohamed Zidanb, Marwa A.A. Galala,
Autor para correspondencia
marwa.a.galal@aun.edu.eg

Corresponding author.
a Rheumatology, Rehabilitation and Physical Medicine Department, Assiut University Hospitals Faculty of Medicine, Assiut University, Egypt
b Radiodiagnosis Department, Assiut University Hospitals Faculty of Medicine, Assiut University, Egypt
Este artículo ha recibido
Información del artículo
Resumen
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Figuras (3)
Mostrar másMostrar menos
Tablas (2)
Table 1. Demographic and clinical data in study and control groups.
Table 2. Imaging features of the study groups, comparing both MRI techniques (FLAIR/DWI) among patinets and controls.
Mostrar másMostrar menos
Abstract
Background

Systemic sclerosis (SSc) is a rare chronic multi-system autoimmune disease of unknown cause and a complex pathogenesis. The hallmark of the disease is microvascular vasculopathy which results in tissue ischemia with recurrent episodes of reperfusion. Diffusion-weighted (DW) Magnetic Resonance imaging (MRI) is an excellent tool for the detection of activity of any vascular or inflammatory lesions.

Objectives

Detect brain changes in systemic sclerosis patients with asymptomatic CNS manifestations using fluid attenuation inversion recovery (FLAIR) weighted sequence and diffusion-weighted (DW) sequence MRI.

Methods

Fifteen systemic sclerosis female patients aged 27–60 years old with disease duration of 1–20 years with no CNS clinical manifestations were included. A controlled group of 14 clinically normal persons, age and sex matched. Both groups were subjected to brain MR examination at 1.5T; a FLAIR weighted sequence and a DW sequence. SPSS (version 20) was used for statistical analysis.

Results

37 white matter hyperintense lesions (≤2 to ≥ 5mm in diameter) were detected in patient group using FLAIR weighted MRI while diffusion-weighted MRI failed to detect the same lesions. A non-significant relation (P=.259) between the presence of white matter hyperintense lesions and the severity of peripheral vascular affection of the disease was observed.

Conclusions

Asymptomatic central nervous system vasculopathy is detected in systemic sclerosis using FLAIR MRI, while diffusion MRI failed to detect such lesions. These findings suggest a non-inflammatory form of central nervous system microvasculopathy in SSc patients.

Keywords:
SSc brain finding
SSc Brain FLAIR MRI
SSc Brain FLAIR versus Diffusion MRI
Resumen
Fundamento

La esclerosis sistémica (SSc) es una rara enfermedad crónica autoinmune multisistémica de causa desconocida y una patogénesis compleja. El sello distintivo de la enfermedad es la vasculopatía microvascular que se traduce en isquemia tisular con episodios recurrentes de reperfusión. La resonancia magnética (RM) ponderada por difusión (DW) es una excelente herramienta para la detección de la actividad de cualquier lesión vascular o inflamatoria.

Objetivos

Detectar cambios cerebrales en pacientes con SSc con manifestaciones del sistema nervioso central (SNC) asintomáticas utilizando FLAIR y DW-RM.

Métodos

Quince pacientes con SSc sin manifestaciones del SNC incluidos. Un grupo de 14 personas sanas estandarizadas por edad y sexo en el grupo de pacientes como grupo de control. La RM cerebral se hizo para obtener ambos grupos (pacientes y control) en 1,5T. La prueba de Chi-cuadrado y la prueba de correlación de Spearman SPSS® (versión 20) se utilizaron para el análisis estadístico.

Resultados

Se detectaron 37 lesiones hiperintensas de materia blanca (≤2-≥5mm de diámetro) en el grupo de pacientes que utilizaron RM ponderada con FLAIR, mientras que la DW-RM no detectó las mismas lesiones. Se observó una relación no significativa (p=0,259) entre la presencia de lesiones hiperintensas de la materia blanca y la severidad del afecto vascular periférico de la enfermedad.

Conclusiones

La vasculopatía del SNC asintomática se detecta en la SSc mediante la RM de FLAIR, mientras que la RM de difusión no detectó tales lesiones. Estos hallazgos sugieren una forma no inflamatoria de la microvasculopatía del SNC en pacientes con SSc.

Palabras clave:
Hallazgo cerebral de esclerosis sistémica
Resonancia magnética del cerebro de esclerosis sistémica
Resonancia magnética del cerebro de esclerosis sistémica versus difusión de la resonancia magnética
Texto completo
Introduction

Systemic sclerosis (SSc) is a rare chronic autoimmune disease, with multi-organ affection, of unknown cause and a complex pathogenesis. This multi-system affection exhibits evidence of inflammation, vasculopathy, autoimmunity, and fibrosis.

The major pathologic components of SSc are vascular disease and progressive fibrosis. The vasculopathy is either microvascular (which is the hallmark of the disease) or macrovascular, resulting in tissue ischemia with recurrent episodes of reperfusion.1–4

Diffusion-weighted Magnetic Resonance (MR) imaging (DWI) is an advanced MR imaging technique, which allows non-invasive evaluation of water diffusibility in brain tissue, as first described by Stejskal and Tanner in 1965.5–8 DWI is sensitive to the random translational motion of water molecules due to Brownian motion. Diffusion weighted images (DW-images) are generated by adding an opposing pair of diffusion gradients to spin-echo or echo planar imaging sequences. For stationary molecules, the effects of the first (tagging) and the second (un-tagging) gradient pulses cancel each other out. For mobile, diffusible molecules there is incomplete rephrasing resulting in a net phase shift, which leads to a signal loss. In practice, tissue with restricted diffusion will appear hyperintense to normal tissue on DW-images.5,6

During the last few years, DWI has been shown to be an excellent tool for the detection of acute stroke (gives us an idea about the ischemic and salvageable area to guide the management). As well as activity of any vascular or inflammatory lesions (e.g. vasculitis or vasculopathy) where DWI can detect small and active changes and differentiate ischemic disease process from others. Furthermore, old brain lesions (3–6 months old), where tissues were deprived from blood supply, appear as hypointense lesions (different shades of gray to black) in a radiologic terminology called encephalomalacia.9–14

Material and methods

Fifteen patients, diagnosed according to the American College of Rheumatology (ACR) criteria for the diagnosis of systemic sclerosis,15 attending the Rheumatology, Rehabilitation & Physical medicine outpatient clinic in Assiut University Hospitals were studied.

The study protocol was approved by the Ethics Review Board of Faculty of Medicine, Assiut University, and informed consent was obtained from all participants according to the Declaration of Helsinki.

Their ages ranged between 27 and 60 years (42±10.18), with disease duration between 1 and 20 years (7.8±6.8). All patients were subjected to full history taking, clinical and basic laboratory evaluation (CBC, ESR, liver function tests, kidney function tests, fasting blood sugar, and lipid profile) in addition to pulmonary function tests, and echocardiography. Radiological evaluation and imaging using plain chest radiographs, high-resolution CT chest, and abdominal ultrasound were also done. The Medsger scale of disease severity was used.16 None of the patients had any history of cerebrovascular accidents, head trauma, or clinical evidences of neuropsychiatric disease.

Patients who suffered severe or uncontrolled arterial hypertension, uncontrolled diabetes mellitus, renal, hepatic, or respiratory failure were excluded from the study.

Fourteen healthy volunteers, sex and age matched with the studied group, were enrolled in the study serving as a control group.

Both groups were subjected to brain MR examination at 1.5T (Achieva, Philips, Netherlands). After centering with a three-step scout (axial, coronal, and sagittal), an axial spin echo, FLAIR weighted sequence was acquired with the following technical parameters: time of repetition/time of echo=11,000/140, matrix 232/512; field of view 230mm with thickness of 5mm (1mm gap), for a total of 23 images with NSA 2. The FLAIR images were used for counting focal brain abnormalities in both patients with SSc and the CG. The FLAIR is higher sensitive sequence for periventricular lesions in white matter than other weighted images. Diffusion weighted sequence performed as echo-planar sequence in following parameters; time of repetition/time of echo=3773/117, matrix 152/256; field of view 230mm with thickness of 5mm (1mm gap), for a total of 23 images with NSA 1 and EPI factor 55. The DW images were acquired in 0 and 1000s/mm2 and the diffusion gradients applied simultaneously in three orthogonal spatial directions.

These images were evaluated by the radiologist. He counted the white matter hyperintensities in all brain regions. All the abnormalities were electronically measured (along the longest diameter) to distinguish the lesions ≥2mm or less.

For statistical analysis, data was analyzed by using the advanced Statistical Package for Social Sciences (SPSS) program version 20. Chi-square test and Spearman's correlation test was used to examine the relation and correlation between continuous variables. P-Value was considered statistically significant when it was ≤.05.

Results

All patients were females. Nine of them had limited SSc (60%), while the rest of them had diffuse type (40%).

Thirteen patients (86.7%) suffered peripheral vascular affection (Raynaud's disease) as 7 of them (46.7%) had moderate vascular affection, while 5 patients (33.3%) suffered severe vascular affection and one patient (6.7%) had mild peripheral vascular affection according to Medsger SSc severity scale (Table 1).

Table 1.

Demographic and clinical data in study and control groups.

Item  Patients (n=14)  Controls (n=14) 
Age (years)  27–60 (42±10.18)  25–64 (40.13±8.51) 
Sex
Male 
Female  15  14 
Disease duration (years)  1–20 (7.8±6.8)  – 
Systemic sclerosis (SSc) subtype:
Limited SSc  9 (60%)  – 
Diffuse SSc  6 (40%)   
Raynaud's disease  13 (86.7%)  – 
Medsger scale for severity of peripheral vascular affection    – 
Normal  2(13.3)   
Mild  1 (6.7)   
Moderate  7 (46.7)   
Severe  5 (33.3)   
End stage   

A total of 37 of white matter hyperintense (WMH) lesions were detected in the patients group; 26 lesions <2mm and 11 lesions ≥2mm (8 of them were ≥5mm in diameter), using the FLAIR MRI. The number of lesions in one patient ranged between one solitary lesion to 18 WMH lesions.

Six patients (40%) showed brain lesions using FLAIR MRI (in different supratentorial deep and subcortical brain regions (Table 2, Figs. 1 and 2). Three (20%) of them had severe peripheral vascular affection, while each of the remaining patients had mild, moderate or no peripheral vascular affection. Diffusion weighted MRI failed to detect any hypo- nor hyper-intense lesions (Table 2). A non-significant relation (P=.259) between the presence of WMH lesions and the severity of peripheral vascular affection of the disease (Medsgar Vascular Score) (Fig. 3), as well as non-significant strong correlation was found (r=0.085, P=.764) was also observed.

Table 2.

Imaging features of the study groups, comparing both MRI techniques (FLAIR/DWI) among patinets and controls.

Imaging features of the study group  Patients (n=15) (%)  Controls (n=14) 
Brain diffusion MRI 
Brain FLAIR MRI
No lesions (−ve)  9 (60%)  14 (100%) 
Hyperintense lesions (+ve)  6 (40%) 
Total numbers of lesions  37 
Number of lesions<2mm  26   
Number of lesions2mm   
Number of lesions5mm   

−ve: absence of lesions; +ve: presence of lesions.

Fig. 1.

A female patient aged (27 years) and suffered from SS since (3 years). (A) FLAIR MRI shows a rather-defined single hyperintense signal lesion seen at deep periventricular white matter of the parietal regions with no comparable signal abnormality on DWI (B) suggesting late subacute to chronic ischemic lesions.

(0.15MB).
Fig. 2.

A female patient aged (60 years) and suffered from SS since (4 years). (A) FLAIR MRI shows multiple rather-defined hyperintense signal foci seen at deep periventricular white matter of both parietal regions with no comparable signal abnormality on DWI (B) suggesting late subacute to chronic ischemic lesions.

(0.15MB).
Fig. 3.

The relation between MRI and vascular severity (Medsger Vascular Score).

(0.11MB).

None of the control group showed any visible white matter lesion in either MRI techniques.

Discussion

Systemic sclerosis represents a complex autoimmune collagen disease that is characterized by multisystem affection. Central nervous system (CNS) involvement is known to be rare and unusual in such disease and is claimed to be related to the disease complications.17–19 This rarity was attributed to the limited presence of extracellular matrix collagens in cerebral tissue with the following sparing of media and adventitia of cerebral arteries and so, the limited progression of vascular obliteration.20–22

On the base of the high sensitivity of MRI to detect different vascular insults in the brain, we aimed to evaluate silent brain affection in SSc patients using two different MRI techniques (FLAIR and DW). The current study detected brain changes in SSc patients with asymptomatic CNS manifestations using FLAIR sequence, while diffusion MRI failed to detect the same lesions. The FLAIR technique results (in the matter of site and size of the lesions), were found to be consistent with the results of different studies.22–25 These white matter hyperintenisty (WMH) lesions where considered by the radiologist to be a definite sign of previous microvascular insults (ischemic demyelination), which additionally supports the ischemic non-inflammatory microvasculopathy theory of brain injury in these patients.23,24

Unfortunately, the completely negative DW images could not support the previous theory, as it was expected to find evidences of brain vascular insults in form of hypointense lesions that correspond to hyperintense lesions seen in FLAIR films. In year 2000, Oppenheim and her team, also found false negative DW MRI results in patients suffering acute ischemic stroke, especially transient ischemic attacks which remained negative even in their follow up DW Images.12,13 These findings can support ours in the light of the resemblance between transient ischemic attacks and the reperfusion that happen in microangiopathy in SSc, besides the limited presence of extracellular matrix collagens in the cerebral tissue, sparing of cerebral arteries media & adventitia.20,21

Furthermore, these negative DW images may be due to technique issue where the lesions are too small to be detected by DWI (of 1.5T magnet) not by the FLAIR images, based on the fact the FLAIR with high spatial resolution displayed a signal abnormality in half the lesions that were not visible on DWI.12,13

Although the results showed non-significant very weak correlation (r=0.085) between presence of brain MRI findings and presence of peripheral microvascular involvement, but we could not exclude the cerebral ischemic microvasculopathy, as multiple WMH were greater in SSc patients with cerebral hypoperfusion.24–26

This study had some limitations, such as small number of examined patients, the absence of detailed psychologic and intellectual evaluation which might give us an idea about their relationship with small infarcts detected by conventional MRI. In addition to some limitations of DWI technique used, as it is susceptible to false-negative images especially when small punctate infarcts are present in proximity to skull base. Also, the imaging plane (axial or coronal) which comes on the expense of decreased signal-to-noise ratio and increased imaging time and a clear diagnostic benefit that still to be proven, as well as the Magnet power (3T DWI is better than 1.5T DWI).13,27–29

It is concluded that asymptomatic CNS vasculopathy is detected in systemic sclerosis using FLAIR MRI, while diffusion MRI will not be cost effective to detect such lesions. Furthermore, these findings suggest a non-inflammatory form of CNS microvasculopathy in SSc patients and we recommend further research work associating intellectual and psychological affection of such CNS asymptomatic patients with imaging finding.

Funding

No funding was received.

Conflicts of interest

The authors declare no conflicts of interest.

Acknowledgment

We acknowledge all the subjects who participated in this work and made it possible.

References
[1]
J.D. Pearson.
The endothelium: its role in scleroderma.
Ann Rheum Dis, 50 (1991), pp. 866-871
[2]
A.D. Blann, K. Illingworth, M.I.V. Layson.
Mechanisms of endothelial damage in systemic sclerosis and Raynaud's phenomenon.
J Rheumatol, 20 (1993), pp. 1325-1330
[3]
J. Varga, D. Abraham.
Systemic sclerosis: a prototypic multisystem fibrotic disorder.
J Clin Invest, 117 (2007), pp. 557-567
[4]
M. Matucci-Cerinic, B. Kahaleh, F.M. Wigley.
Evidence that systemic sclerosis is a vascular disease.
Arthritis Rheum, 65 (2013), pp. 1953-1962
[5]
D. Le Bihan, R. Turner, P. Douek, N. Patronas.
Diffusion MR imaging: clinical applications.
Am J Roentgenol, 159 (1992), pp. 591-599
[6]
J.M. Provenzale, A.G. Sorensen.
Diffusion-weighted MR imaging in acute stroke: theoretic considerations and clinical applications.
Am J Roentgenol, 173 (1999), pp. 1459-1467
[7]
E.O. Stejskal, J.E. Tanner.
Spin diffusion measurements: spin echo in the presence of a time dependent field gradient.
J Chem Phys, 42 (1965), pp. 288-292
[8]
H. Ay, F.S. Buonanno, P.W. Schaefer, D.A. Le, B. Wang, R.G. Gonzalez, et al.
Posterior leukoencephalopathy without severe hypertension: utility of diffusion weighted MRI.
[9]
K.O. Lövblad, H.J. Laubach, A.E. Baird, F. Curtin, G. Schlaug, R.R. Edelman, et al.
Clinical experience with diffusion-weighted MR in patients with acute stroke.
Am J Neuroradiol, 19 (1998), pp. 1061-1066
[10]
M.B. Singer, J. Chong, D. Lu, W.J. Schonewille, S. Tuhrim, S.W. Atlas.
Diffusion-weighted MRI in acute subcortical infarction.
[11]
R.G. González, P.W. Schaefer, F.S. Buonanno, L.H. Schwamm, R.F. Budzik, G. Guy Rordorf, et al.
Diffusion weighted MR imaging: diagnostic accuracy in patients imaged within 6hours of stroke symptom onset.
[12]
C. Oppenheim, M. Logak, D. Dormont, S. Lehéricy, R. Manaï, Y. Samson, et al.
Diagnosis of acute ischemic stroke with fluid attenuated inversion recovery (FLAIR) and diffusion-weighted MR sequences.
[13]
C. Oppenheim, R. Stanescu, D. Dormont, S. Crozier, B. Marro, Y. Samson, et al.
False-negative diffusion-weighted MR findings in acute ischemic stroke.
Am J Neuroradiol, 21 (2000), pp. 1434-1440
[14]
T. Moritani, A. Hiwatashi, D.A. Shrier, H.Z. Wang, Y. Numaguchi, P.L. Westesson.
CNS vasculitis and vasculopathy: efficacy and usefulness of diffusion-weighted echoplanar MR imaging.
Clin Imaging, 28 (2004), pp. 261-270
[15]
F. van den Hoogen, D. Khanna, J. Fransen, S.R. Johnson, M. Baron, A. Tyndall, et al.
2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism Collaborative Initiative.
Ann Rheum Dis, 72 (2013), pp. 1747-1755
[16]
T.A. Medsger Jr., S. Bombardieri, L. Czirjak, R. Scorza, A. Della Rossa, W. Bencivelli.
Assessment of disease severity and prognosis.
Clin Exp Rheumatol, 21 (2003), pp. S42-S46
[17]
A.L. Herrick.
Neurological involvement in systemic sclerosis.
[18]
M.M. Cerinic, S. Generini, A. Pignone, R. Casale.
The nervous system in systemic sclerosis (scleroderma). Clinical features and pathogenetic mechanisms.
Rheum Dis Clin North Am, 22 (1996), pp. 879-892
[19]
T.N. Amaral, F.A. Peres, A.T. Lapa, J.F. Marques-Neto, S. Appenzeller.
Neurologic involvement in scleroderma: a systematic review.
Semin Arthritis Rheum, 43 (2013), pp. 335-347
[20]
R.A. Dierckx, Aichner f, F. Gerstembrand, P. Fritsch.
Progressive systemic sclerosis and nervous system involvement.
Eur Neurol, 26 (1987), pp. 134-140
[21]
L. Averbuch-Heller, I. Steiner, O. Abramsky.
Neurologic manifestations of progressive systemic sclerosis.
Arch Neurol, 49 (1992), pp. 1292-1295
[22]
M. Cutolo, F. Nobili, A. Sulli, C. Pizzorni, M. Briata, F. Faelli, et al.
Evidence of cerebral hypoperfusion in scleroderma patients.
Rheumatology, 39 (2000), pp. 1366-1373
[23]
F. Sardanelli, A. Lozzelli, B. Cotticelli, C. Losacco, M. Cutolo, A. Sulli, et al.
White matter hyperintensities on brain magnetic resonance in systemic sclerosis.
Ann Rheum Dis, 64 (2005), pp. 777-779
[24]
R.H.A. Mohamed, A.A. Nassef.
Brain magnetic resonance imaging findings in patients with systemic sclerosis.
Int J Rheum Dis, 13 (2010), pp. 61-67
[25]
R.H.A. Mohammed, Y.Y. Sabry, A.A. Nasef.
Brain MRI screening showing evidences of early central nervous system involvement in patients with systemic sclerosis.
Rheumatol Int, 31 (2011), pp. 667-671
[26]
F. Nobili, M. Cutolo, A. Sulli, A. Castaldi, F. Sardanelli, S. Accardo, et al.
Impaired quantitative cerebral blood flow in scleroderma patients.
[27]
W. Kuker, J. Weise, H. Krapf, F. Schmidt, S. Friese, M. Bähr.
MRI characteristics of acute and subacute brainstem and thalamic infarctions: value of T2- and diffusion-weighted sequences.
J Neurol, 249 (2002), pp. 33-42
[28]
J.R. Meyer, A. Gutierrez, B. Mock, D. Hebron, J.M. Prager, M.T. Gorey, et al.
High-b-value diffusion-weighted MR imaging of suspected brain infarction.
Am J Neuroradiol, 21 (2000), pp. 1821-1829
[29]
M. Cihangiroglu, B. Citci, O. Kilickesmez, Z. Firat, G. Karlıkaya, A.M. Uluğ, et al.
The utility of high b-value DWI in evaluation of ischemic stroke at 3T.
Eur J Radiol, 78 (2011), pp. 75-81
Copyright © 2019. Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología
Descargar PDF
Idiomas
Reumatología Clínica
Opciones de artículo
Herramientas
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?